Lymphoma
Lymphoma
Lymphoma
The malignant cell of Hodgkin lymphoma is the Reed Sternberg cell( These cells arise
from the B lymphocyte).
They may have more than one nucleus and often have an owl like appearance
The presence of Reed-Stemberg cells is the patho logic diagnostic criteria of Hodgkin
lymphoma
Clinical manifestation of Hodgkin
lymphoma
Hodgkin lymphoma usually begins as an enlargement of one or more lymph nodes on one side
of the neck
Supraclavicular and mediastinal nodes
Compress trachea
Dyspnea
Compression of organs by the tumor, such as cough and pulmonary effusion (from pulmonary
infiltrates) Jaundice (from hepatic involvement or bile duct obstruction)
Abdominal pain (from splenomegaly or retroperitoneal adenopathy
Bone pain (from skeletal involvement).
Pruritus
Fatigue, decreased appetite,
Impaired cellular immunity increased susceptibility to infections
Particularly herpes zoster
Diagnostic evaluationof Hodgkin lymphoma
Etiology
Although no common etiologic factor has been identified
Immune deficiencies or autoimmune disorders;
Organ transplant recipient;
History of viral infections , HIV,
Exposed to herbicides, pesticides, solvents, dyes, and defoliating
agents
Clinical manifestation of NHL
Painless swelling in one or more lymph
NHL in the neck, axillary region, or groin.
Mediastinum can cause cough, shortness of breath, and chest pain
Cardio- vascular
Respiratory distress.
Acute kidney injury
Bowel obstruction.
Splenomegaly can cause abdominal pain, nausea, early satiety, and
weight loss.
Diagnostic evaluation of NHL
Lymph node biopsy
Flow cytometry
FISH fluorescence situ hybridization
Laboratory studies
PCR
CT SCAN
PET SCAN
ECG
Medical Management of NHL
The goal of treatment for NHL is to obtain remission of disease by killing as many of the
malignant cells as possible
Treatment for NHL is based upon the specific subtype of lymphoma and the stage of
disease.
If the disease is indolent and localized, the treatment of choice may be radiation therapy
alone.
For aggressive subtypes of NHL, combination chemotherapy is typically indicated. A
MoAb may be given along with the chemotherapy .
Radiation therapy may or may not be added to the treatment regimen. In some cases, a
MoAb may be conjugated with a radioactive isotope and used for treatment CNS
involvement is common with some aggressive forms of NHL, in this situation, cranial
radiation or intrathecal chemotherapy is used in addition to systemic chemotherapy.
Complications of NHL
Tumor Lysis syndrome
Reactivation of hepatitis B
Progressive multifocal leukoencephalopathy
Respiratory compromise
Nursing management of NHL
When caring for patients with lymphoma, it is extremely important for the nurse to know the
specific disease type, stage of disease, treatment history, and current treatment plan.
Most of the care for patients with Hodgkin lymphoma or NHL takes place in the outpatient
setting, unless complications occur
Patients need to be educated to minimize the risks of infection, to recognize signs of
possible infection, and to contact their primary provider if such signs develop
survivors should be screened regularly for the development of second malignancies.
Survivors of both Hodgkin lymphoma and NHL may be faced with managing persistent
fatigue, depression, anxiety, and cardiac and pul monary toxicity
Survivors should be encouraged to have regular follow-up appointments and be screened for
the signs and symptoms of possible secondary malignancies.
Additionally, patients should be evaluated for cardiovascular and fertility concerns with each
patient visit. Pt should maintaining a normal body weight, and engaging in a minimum of 150
minutes of exercise per week
Difference between HL and NHL
REFERENCE ;